📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms. (2019)

First Author: Francis S
Attributed to:  Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjh.16193

PubMed Identifier: 31525819

Publication URI: http://europepmc.org/abstract/MED/31525819

Type: Journal Article/Review

Volume: 187

Parent Publication: British journal of haematology

Issue: 3

ISSN: 0007-1048